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The production of high quality milk is a requirement to sustain a profitable dairy 
industry and somatic cell count (SCC) values are routinely used to identify subclinical 
mastitis and define quality standards. The objective of this paper is to review the use 
of SCC as a diagnostic tool for subclinical mastitis in order to improve milk quality on 
dairy farms. Mastitis is detected based on inflammation subsequent to intramammary 
infection (IMI) by pathogenic organisms. Individual cow SCC values are used to detect 
the inflammation that results from IMI and are necessary to define the prevalence and 
incidence of subclinical IMI. A threshold of <200,000 cells/mL is considered to be of 
the most practical value used to define a mammary quarter as healthy. The develop-
ment of IMI is the most significant factor that influences milk SCC and assessment 
of monthly values to determine newly and chronically increased SCC can be highly 
diagnostic for resolving problems with increased bulk tank SCC. Methods to reduce the 
development of new IMI are well known and adoption of best management practices for 
milking and herd management have consistently been shown to result in reductions in 
bulk tank SCC. Implementation of mastitis control programmes can be improved by 
focusing on three practical recommendations: 1) Farmers should work with their advi-
sors to develop an annual udder health plan that includes clear goals for milk quality. 
2) The annual udder health plan should emphasise prevention of new IMI. 3) Farmers 
must identify and manage chronically infected cows. Proactive management of IMI can 
be extremely effective in helping farmers produce milk that meets industry standards 
for milk quality.
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Introduction
In most developed countries, mastitis is 
the most common infectious disease of 
dairy cows and results in considerable eco-
nomic loss for both dairy farmers and milk 
processors (Fetrow et al. 2000; Halasa 
et al. 2007; Geary et al. 2012). The eco-
nomic impact of mastitis is greater than 
most other infectious diseases because 
the point of infection is the mamma-
ry gland; thus intramammary infection 
(IMI) results in reduced productive capac-
ity of the gland and decreased processing 
value of milk (Barbano, Ma and Santos 
2006). Inflammation subsequent to IMI 
can result in subclinical and/or clinical 
symptoms and control programmes must 
include methods to detect and monitor 
outcomes of both presentations of the 
disease (Ruegg 2011).
Minimising mastitis and consistently 
producing high quality milk is a require-
ment for dairy farmers who wish to be 
competitive in the global marketplace. 
Enumeration of the somatic cell count 
(SCC) of milk has long been used as a tool 
for measuring milk quality (Dohoo and 
Leslie 1991). Bulk tank SCC (BTSCC) 
values are routinely used to define the 
national and international regulatory stan-
dards that govern hygienic milk produc-
tion. The national standards for BTSCC 
vary from <400,000 cells/mL (EU, 
Australia, New Zealand and Canada) 
to <1,000,000 cells/mL (Brazil) (USDA 
2013). However, minimum international 
export requirements for milk quality are 
becoming more important than national 
regulations. The US situation is a good 
example of how market forces can result 
in rapid improvements in BTSCC, even in 
the absence of rigorous national regula-
tions. While several US states have more 
stringent standards, the legal maximum 
BTSCC for most US states remains at 
750,000 cells/mL (FDA 2011). However, 
exports of US dairy products are increas-
ing. In 2012, 13.2% of US milk production 
was exported, including approximately 
45–47% of whey proteins and skim milk 
powder/non-fat dry milk (US Dairy Export 
Council 2013). To ensure that US products 
remain eligible for export to EU nations, 
the USDA introduced a programme that 
allows processors to obtain an export 
certificate that verifies farm-level com-
pliance with the 400,000 cell/mL limit 
adopted in the EU (USDA 2011). Most 
large milk processors have enrolled in this 
programme and enforce the more strin-
gent requirements. The sustained industry 
emphasis on improved BTSCC has result-
ed in continued reductions in BTSCC, 
even though national regulations have 
not changed (Figure 1) (USDA 2013). 
These improvements demonstrate that 
dairy farmers can produce high quality 
milk in response to market demands and 
indicate that processors have considerable 
leverage in motivating farmers to adopt 
management practices that contribute to 
the production of high quality milk.
Bulk tank SCC is used to measure the 
quality of the milk produced by a herd, 
but measurement of SCC at the cow-level 
is necessary to estimate prevalence and 
incidence of subclinical mastitis. In most 
instances, monthly composite milk SCC 
values from Dairy Herd Improvement pro-
grammes (DHI) are used to monitor the 
dynamics of IMI (as estimated by SCC) at 
the herd and cow-level (Figure 2) (Laevens 
et al. 1997; Ruegg 2003). Monthly reports 
that are generated using SCC values 
can be used to monitor herd and group 
SCC and to identify subclinically affected 
cows for interventions such as culture, 
segregation, treatment, or removal from 
the herd (Cook et al. 2002; Rhoda and 
Pantoja 2012). Enrolment in a DHI test-
ing programme is essential for managing 
udder health and has been associated with 
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reduced prevalence of subclinical mastitis 
(Wilson, Gonzalez and Sears 1997). The 
objective of this paper is to review the use 
of SCC as a diagnostic tool for improving 
milk quality on dairy farms.
Detecting Intramammary Infection and 
Inflammation
The technical definition of mastitis is 
“inflammation of the mammary gland” 
but on a practical basis, almost all mastitis 
occurring in dairy cows is caused by bac-
teria, although some cases are caused by 
yeasts, fungi or algae (Hogan et al. 1999). 
Mastitis is initiated after an infective dose 
of a pathogenic organism passes through 
the streak canal, followed by bacterial 
growth during an incubation period and 
then progression to either subclinical or 
clinical states or resolution of the infection 
as a result of the cows immune response 
(Ovideo-Boyso et al. 2007). Mastitis is 
virtually never detected at the precise 
moment of infection but is recognised 
based on observation of the resulting 
inflammation. Thus, the presentation of 
mastitis (as a clinical or subclinical case) 
depends on pathogen and cow charac-
teristics that influence the extent of the 
immune response, whereas recognition by 
farm personnel depends on the intensity 
and accuracy of the detection methods 
(Ruegg and Erskine, in press). 
Consistency in collection of samples 
used for analysis of SCC is important 
because the milk fraction from which 
samples are collected can influence SCC. 
In general, in both healthy and infected 
quarters, concentrations of SCC are great-
est in foremilk and post-milking strip-
pings and least in milk collected during 
peak flow (Urech, Puhan and Schällibaum 
1999; Bansal et al. 2005; Nielsen et al. 
2005; Sarikaya and Bruckmaier 2006). 
The time interval between milking periods 
influences the magnitude of this diur-
nal variation (Reneau 1986). Somatic cell 
counts have been reported to be greater 
in milk samples collected in the evening 
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Figure 1. Trends in bulk tank somatic cell count in US states monitored by the Federal Milk 
Mark Orders (representing 47% of milk produced in the US) (adapted from USDA 2013).
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as compared to samples collected in the 
morning (Reneau 1986). Although failure 
to consider diurnal variation of SCC will 
probably not affect diagnosis of major 
pathogens, it may lead to misclassification 
errors. 
By definition, milk obtained from mam-
mary gland quarters of cows experiencing 
subclinical mastitis appears visually normal 
(even when millions of somatic cells are 
present) but contain an excessive num-
ber of somatic cells, (with or without the 
detectable presence of pathogenic organ-
isms) (Dohoo and Leslie 1991). Somatic 
cells in milk consist of neutrophils, mac-
rophages, lymphocytes, and a smaller 
percentage of epithelial cells (Sordillo, 
Shafer-Weaver and DeRosa 1997). The 
SCC of healthy quarters is usually well 
below 100,000 cells/mL and is composed 
primarily of macrophages (Hamann 2005). 
After establishment of IMI, inflammatory 
mediators attract large numbers of phago-
cytes to migrate from the bloodstream 
to the udder, dramatically increasing the 
SCC in milk and shifting the distribution 
of cells from macrophages to primarily 
neutrophils. 
Detection of subclinical mastitis is based 
on measurement of SCC in milk collected 
from individual mammary gland quarters 
or composite milk samples that are a 
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Figure 2. Example of summarised somatic cell count report for one herd.
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mixture of milk from all functional glands 
of an individual cow. Composite milk 
samples collected through milk meters 
are routinely used in DHI programmes 
for monitoring SCC of individual cows. 
It is important to recognise that each 
mammary gland quarter becomes infected 
independently, so most infections occur 
in single quarters. When composite milk 
samples are used, some subclinical infec-
tions will not be detected because the SCC 
in the sample will be reduced by dilution 
with milk from healthy quarters that con-
tain few somatic cells (Figure 3) (Ruegg 
and Reinemann 2002; Ruegg 2011). 
The most accurate relationship between 
IMI and SCC exists at quarter level 
(Schukken et al. 2003). Researchers have 
reported that uninfected quarters have 
a mean SCC of approximately 70,000 
cells/mL and reduced milk yield is observed 
once cell counts exceed 100,000 cells/mL 
(Schukken et al. 2003). While the SCC 
of healthy quarters is consistently quite 
low and usually remains below 100,000 
cells/mL (Hamann 2005), a threshold of 
<200,000 cells/mL is usually considered 
to be the most practical value to use to 
define a mammary quarter as healthy 
(Dohoo and Leslie 1991; Schepers et al. 
1997; Djabari et al. 2002; Pantoja, Hulland 
and Ruegg 2009). The probability of iso-
lating a major pathogen increases as SCC 
exceeds 200,000 cells/mL. When SCC 
are used for detection of IMI, a thresh-
old of approximately 200,000 to 250,000 
cells/mL has been considered optimal to 
reduce diagnostic error under field condi-
tions (Dohoo and Leslie 1991; Schepers 
et al. 1997; Djabri et al. 2002). 
The selection of the appropriate thresh-
old for defining subclinical mastitis is 
dependent on the goal of the control pro-
gramme. When the goal is to detect micro-
biologically positive quarters, the use of 
lower thresholds will identify more animals 
with IMI (increased sensitivity and fewer 
false negatives) whereas the use of high-
er thresholds (increased specificity) will 
result in fewer false positives (Pantoja et al. 
2009). Regardless of the threshold selected, 
review of the SCC history of a cow is much 
more informative as compared to observa-
tion of a single monthly value. 
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Figure 3. Example of estimated composite milk somatic cell count (from all four quarters) 
when a single mammary gland quarter is infected and the baseline SCC in uninfected quar-
ters is 100,000 cells/mL.
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The occurrence of SCC >200,000 cells/
mL is an extremely specific indicator of 
IMI, but the failure to recover bacteria 
from a high SCC gland does not indicate 
that the gland is healthy. An increased 
SCC in a microbiologically negative milk 
sample is a common occurrence that can 
occur because the immune response has 
reduced the number of bacteria to below 
normal laboratory detection limits (usu-
ally 100 cfu/mL). The increased SCC 
is part of an immune response that has 
the purpose of elimination of pathogens. 
This response is often effective and at 
least 10–25% of quarters that have SCC 
>200,000 cells/mL will be apparently 
bacteriologically negative (Dohoo and 
Leslie 1991; Schepers et al. 1997; Pantoja 
et al. 2009). When using monthly SCC 
data to identify potentially infected cows, 
the positive predictive value (PPV) for 
recovery of bacteria (IMI) is relatively 
poor for dairy herds that have moder-
ate prevalence of subclinical infections. 
In recent research, the PPV (defined 
as the probability of recovering mastitis 
pathogens from milk samples when the 
first test SCC was >200,000 cells/mL) 
was only 41% (Pantoja et al. 2009). In 
contrast, the negative predictive value 
(NPV; defined as the probability of NOT 
recovering mastitis pathogens from milk 
samples when the first test SCC was 
<200,000 cells/mL) was 85%. This indi-
cates that farmers should be educated 
to expect that many milk samples used 
to determine aetiology of IMI are likely 
to be negative and results of single milk 
samples should not be over-interpreted 
relative to infection status nor treat-
ment efficacy. After effective treatment 
or spontaneous cure, the SCC will gradu-
ally return to <200,000 cells/mL, but the 
time required to return to normal is often 
dependent on the aetiology (de Haas 
et al. 2004; Ruegg 2013). 
The SCC values of individual cows are 
not usually normally distributed so arith-
metic mean values of groups or herds 
may not be representative of the preva-
lence of IMI. To account for the skewed 
distribution, most North American 
DHI centres report SCC using a linear 
score transformation (usually termed 
Somatic Cell Score; SCS), which is cal-
culated using a simple formula (LS=log2 
(SCC/100)+3). The use of SCS removes 
the influence of very high values and is 
associated with a linear reduction in milk 
yield. When linear scores are used, each 
1 unit increase in SCS has been dem-
onstrated to result in 91 kg and 182 kg 
reductions in milk yield for primiparous 
and multiparous cows, respectively (Ali 
and Shook 1980).
Clinical Mastitis
Clinical mastitis is defined as inflamma-
tion that results in visible abnormalities 
of milk, regardless of SCC level. Hygienic 
regulations usually require that abnor-
mal milk is discarded (FDA 2011), thus 
if the cases are accurately detected, the 
occurrence of clinical mastitis should not 
contribute to increased BTSCC. However, 
most symptoms of clinical mastitis are 
quite mild and cannot be detected unless 
foremilk is observed before attaching the 
milking cluster. In a study that enrolled 
almost 800 cases of clinical mastitis occur-
ring on 51 Wisconsin dairy farms, only 
15% of clinical cases presented with sys-
temic symptoms, while 50% and 35% 
of cases presented with solely abnormal 
milk or abnormal milk and swelling of the 
affected quarter, respectfully (Oliveira, 
Hulland and Ruegg, 2013). 
The relationship between the subclini-
cal and clinical phases of IMI is depen-
dent on aetiology (Sheldrake et al. 1983; 
Smith, Todhunter and Schoenberger 
1985; Schepers et al. 1997). Many 
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Gram-positive IMI have long subclinical 
phases before the occurrence of a clini-
cal case while most Gram-negative IMI 
have relatively short subclinical phases 
as compared to Gram-positive pathogens 
(Smith et al. 1985, de Haas, Barkema 
and Veerkamp 2002). Pathogen specif-
ic SCC patterns before and after the 
occurrence of clinical cases have been 
evaluated in the past (de Haas et al. 2002, 
2004). A period of subclinical infection 
with increased SCC was observed before 
cases of clinical  mastitis associated with 
typical Gram-positive mastitis pathogens 
(Staphylococcus aureus, Streptococcus dys-
galactiae, Streptococcus uberis, and other 
Streptococci), whereas SCC values were 
generally <200,000 cells/mL before the 
occurrence of clinical E. coli mastitis (de 
Haas et al. 2002). Several distinct patterns 
of SCC have been developed based on 
analysis of consecutive test-day records 
(de Haas et al. 2004). These patterns 
differentiated between a short or longer 
period of increased SCC with or without 
recovery and were used with the aim of 
identifying profiles of pathogens causing 
IMI and clinical mastitis in dairy herds. 
After resolution of clinical signs, the SCC 
of clinical cases associated with isolation 
of E. coli or no bacterial growth resulted 
in a relatively rapid return to normal lev-
els of SCC, whereas clinical cases caused 
by Staphylococcus aureus or coagulase- 
negative Staphylococci were associated 
with slow recovery and increased SCC 
during lactation. In contrast, Streptococci 
were not consistently associated with any 
of the defined patterns of peaks i n SCC 
(de Haas et al. 2004). While occurrence 
of clinical mastitis cannot be measured 
using SCC values, a review of the SCC 
history preceding a clinical case can give 
useful clues regarding the potential aeti-
ology and need for antimicrobial therapy 
(Ruegg 2013). For example, a clinical 
case that is preceded by a long history of 
increased SCC is more likely to be a case 
caused by bacteria that may require anti-
biotic therapy as compared to a case that 
has no prior history of inflammation.
Factors that Influence Somatic Cell 
Counts
Immediately after calving, SCC are usu-
ally >1,000,000 cells/mL and decrease 
to approximately 100,000/mL by 7–10 
days after parturition. Barkema et al. 
(1999) reported that the geometric mean 
SCC of cows with culture-negative quar-
ters decreased from 588,000 cells/mL 
on the first day post-calving to 166,000 
cells/mL on the third day after calv-
ing. After initiation of lactation, in the 
absence of IMI, few leucocytes migrate 
into milk and SCC are normally <100,000 
cells/mL. As lactation progresses, both the 
SCC and the proportion of neutrophils in 
milk gradually increase. In the absence 
of apparent IMI, the SCC at the end of 
lactation has been reported to increase in 
very low producing cows, but the increase 
was not significant for cows producing 
more than 4 kg/day on the last DHI test 
(Bodoh, Batista and Schultz 1976). Thus, 
on most modern dairy farms, increased 
SCC at the end of lactation is indicative 
of IMI. Characteristic increases in SCC 
at different stages of lactation will reflect 
exposures to pathogens found on indi-
vidual farms. The timing and duration of 
IMI caused by contagious and environ-
mental pathogens are usually distinctive. 
For example, in herds with many cows 
infected with contagious mastitis patho-
gens, the prevalence of IMI increases with 
parity and stage of lactation because of the 
increased likelihood of exposure to these 
pathogens from milk of subclincally infect-
ed herdmates. In contrast, the incidence 
of IMI (as evidenced by increased SCC) 
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caused by environmental pathogens is usu-
ally greatest in early lactation because 
post-partum immune suppression reduces 
the ability of animal to respond to expo-
sures to these opportunistic pathogens.
Age, number of quarters with IMI (in 
composite samples), season and diurnal 
variation are other significant factors that 
have been associated with SCC (Dohoo 
and Meek 1982; Wiggans and Shook 1987; 
Schepers et al. 1997). As parity advances, 
cows have greater probability of develop-
ing IMI and increased SCC with parity 
may be attributed to increased prevalence 
of IMI and greater cellular response to 
certain pathogens. As expected, when 
composite milk samples are used, there 
is an observed increase in SCC as the 
number of infected quarters increased. 
Seasonal variation in SCC for dairy herds 
in North America and Europe are consis-
tently reported (Ruegg and Tabone 2000; 
Berry et al. 2006; Summer et al. 2007; 
Cicconi-Hogan et al. 2013). In general, 
due to increased exposure to pathogens 
(as a result of favourable climatic condi-
tions for microbial growth) more IMI 
occur in warmer, wetter seasons (such 
as summer) and reduced IMI occur in 
cooler periods (such as winter or spring) 
(Ruegg and Tabone 2000; Berry et al. 
2006; Summer et al. 2007; Cicconi-Hogan 
et al. 2013). There is also some evidence 
that heat stress can reduce the phagocytic 
ability of neutrophils, resulting in reduced 
capability of the cow to respond to IMI 
(do Amaral et al. 2011). Thus, during 
warm and wet seasons, cows experience 
increased exposure to mastitis pathogens 
while simultaneously having decreased 
ability to spontaneously clear pathogens, 
resulting in increased probability of per-
sistent IMI and increased SCC. 
The development of an IMI is the most 
important factor that will affect milk SCC 
for an individual quarter, a cow and at the 
herd-level (Dohoo and Meek 1982). A dif-
ference in SCC response can be observed 
between quarters infected by major (e.g. 
Staphylococcus aureus, streptococci and 
coliforms) and minor pathogens (e.g. 
Corynebacterium spp. and coagulase-neg-
ative Staphylococci). Several studies that 
used various epidemiological approaches 
(retrospective or prospective) and various 
units of analysis (quarter or cow level) 
have shown that minor pathogens nor-
mally induce less intense SCC responses 
than major pathogens. Cows infected with 
minor pathogens have been reported to 
have composite SCC levels that ranged 
from 190,000 to 519,000 cells/mL (aver-
age of 227,000 cells/mL), as opposed to 
cows infected with major pathogens, which 
had SCC greater than 600,000 cells/mL; 
(Sheldrake et al. 1983; Barkema et al. 1999; 
and Schukken et al. 2003). At the cow level, 
experimental studies have demonstrated 
that different pathogens may cause spe-
cific SCC patterns of response after infec-
tion. Quarters with experimental infection 
induced using E. coli had short peaks of 
SCC (at about 2 days after challenge) 
and a period of three to four weeks until 
normalisation (Erskine 1992; Pyorala et al. 
1994). However, within 24 hours after 
inoculation with Staphylococcus aureus, 
SCC increased and remained increased 
for at least 48 days (Shoshani et al. 2000). 
Use of Somatic Cell Counts as 
a Diagnostic Tool for Mastitis
It is impossible to manage any disease with-
out knowledge of the infection status of 
individual animals. The first step in moni-
toring subclinical mastitis is to ensure that 
SCC values are obtained from all cows on a 
regular basis. Generally all cows with com-
posite SCC values >200,000 cells/mL (SCS 
of approximately 4.0) are considered to 
have subclinical mastitis caused by an IMI.
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At the herd-level, evaluation of the pat-
tern of newly and chronically increased 
SCC can be highly diagnostic for trouble-
shooting high BTSCC. For example, when 
many cows have increased SCC in early 
lactation, exposure to environmental mas-
titis pathogens during the dry and transi-
tion periods should be evaluated. In these 
herds, transition and dry cow management 
should be evaluated with special emphasis 
on the condition of pastures, lanes and 
animal housing (during periods of con-
finement). In contrast, when contagious 
mastitis is a problem, the proportion of 
cows with increased SCC usually increases 
as lactation progresses and as cows age 
(because of the longer a cow milks, the 
greater the opportunities for exposure to 
infected milk). In these herds, emphasis 
should be placed on detecting inadequate 
teat dipping or the presence of fomites 
that can transfer infected milk among cows 
(such as towels used to clean or dry teats 
on more than one cow). When a large pro-
portion of cows have chronically increased 
SCC (more than 2 consecutive monthly 
tests with increased SCC) it indicates 
that cows are infected with host adapted 
pathogens that are usually transmitted in 
a contagious manner. In these instances it 
is useful to review a list of individual cows 
sorted by SCC to identify cows that may 
require specific interventions. The use of 
a rapid cow-side quarter-level SCC test, 
can help farmers make important man-
agement decisions such as whether or not 
to segregate, treat, culture, withhold high 
SCC quarters or cull the cow.
Most DHI centres produce a sum-
marised SCC report (Figure 2) that should 
be routinely reviewed to manage udder 
health. Monthly individual cow SCC val-
ues should be summarised to provide esti-
mates of prevalence (usually defined as the 
proportion of cows with SCC >200,000 
cells/mL and to monitor incidence (usually 
defined as the proportion of cows with 
SCC >200,000 cells/mL for the first time 
(Figure 2). Assessments of subclinical 
mastitis should begin with the following 
questions (from Ruegg 2011): 1) What 
is the prevalence of subclinical mastitis? 
2) What is the incidence of subclinical 
mastitis? 3) What are the most common 
bacteria recovered from cows with SCC 
values >200,000 cells/mL? 4) What pro-
portion of subclinical cases are chronic 
(persist more than two months)? 5) What 
is the prevalence of subclinical mastitis by 
days in milk and parity? 6) What propor-
tion of cows have subclinical mastitis at 
the first test and the last test? Common 
key performance indicators for evalua-
tion of subclinical mastitis are: 85% cows 
with somatic cell counts <200,000 (preva-
lence) and <5% of cows developing new 
subclinical mastitis infections per month 
(incidence) (Table 1 – Ruegg 2011). When 
herds do not meet these goals, a plan to 
improve milk quality should be initiated.
Practical Methods to Reduce Somatic 
Cell counts and Improve Milk Quality
Mastitis is a bacterial disease that results 
from insufficient management of people, 
cows, technology, and/or the environ-
ment. Mastitis is a bacterial disease that 
occurs in individual animals but masti-
tis control programmes must be imple-
mented at the herd level. Fortunately, 
methods to control mastitis are well 
known. Numerous studies have indicated 
that effective implementation of best 
management practices results in reduced 
prevalence of IMI and reduced BTSCC 
(Rodrigues, Caraviello and Ruegg 2005; 
Olde Riekerink et al. 2010; Dufour et al. 
2011). However, control of mastitis 
requires a multidisciplinary approach 
that is focused on prevention of new 
infections and appropriate interventions 
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for infected cattle. In general, exposure to 
contagious pathogens is based on reduc-
ing the possibility that teats of healthy 
cows come into contact with milk that 
came from udder of cows with subclinical 
IMI. More than 40 years ago, Neave et al. 
(1969) developed the 5-point plan that is 
the basis for control of contagious patho-
gens. This plan remains effective and in 
regions that have adopted these recom-
mendations, successful control of conta-
gious pathogens has occurred (Makovec 
and Ruegg 2003). However, on many 
modern dairy farms, the BTSCC is low 
but environmental pathogens continue 
to cause excessive cases of clinical mas-
titis (Oliveira et al. 2013). To address the 
increased incidence of mastitis caused 
by environmental pathogens, the NMC 
expanded the 5-point plan to 10-points 
that focus on comprehensive mastitis 
control (NMC 2013). Based on these 
plans, implementation of successful mas-
titis control can be summarized in three 
practical recommendations:
1. Each farm should routinely work 
with their advisors to develop an annual 
udder health plan that includes clear goals 
for milk quality. Barriers to improve-
ment in milk quality are often related to 
motivation and implementation rather 
than lack of technical knowledge or skills 
(Rodrigues and Ruegg 2004). Without 
having clear goals, deadlines to accom-
plish tasks and routine access to advisors, 
few farmers actually set aside sufficient 
time to develop and implement an udder 
health plan. The development, imple-
mentation and evaluation of an annual 
udder health plan can be increased by 
involvement of veterinarians and other 
industry professionals (Rodrigues et al. 
2005; Ruegg 2009). The plan should 
include outcome measurement and 
key performance indicators for manag-
ing mastitis (Ruegg 2011; Anon. 2013a). 
Successful mastitis control is dependent 
on effective detection, accurate diagno-
sis, evaluation of appropriate treatment 
options and implementation of preven-
tive practices that address herd specific 
risk factors associated with exposure to 
mastitis pathogens. Evaluation of cow 
factors, environmental factors and milk-
ing machine factors that can contribute 
to exposure to mastitis pathogens should 
be a considered as the udder health plan 
is developed. An effective surveillance 
system for mastitis includes clear case 
definitions and effective mechanisms to 
detect both clinical and subclinical masti-
tis, the use of recording systems that allow 
for timely evaluation of risk factors and 
feedback mechanisms that allow man-
agement personnel and veterinarians to 
regularly assess progress toward meeting 
the agreed upon goals. Implementation 
of udder health plans is often improved 
when processors provide incentives for 
producing higher quality milk.
2. The annual udder health plan should 
emphasise prevention of new infections. 
Emphasis should be placed on proactive 
planning to prevent new IMI rather than 
reactive strategies to limit losses after 
occurrence of IMI. Management of the 
environment to reduce exposure to patho-
gens is especially important as numerous 
studies have demonstrated that exposure 
to environmental pathogens is strongly 
associated with animal hygiene (Barkema 
et al. 1998; Peeler et al. 2000; Schreiner 
and Ruegg 2003). Maintaining clean 
and dry udder is especially important. 
Using a four point udder hygiene scor-
ing (UHS) system, Schreiner and Ruegg 
(2003) demonstrated that cows that were 
scored as having dirty udders (scores 3 
and 4) were at increased risk of IMI and 
had increased SCC. Forms to perform 
udder hygiene scoring are readily available 
(Anon. 2013b). 
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The milking process is a critical control 
point for limiting new IMI and should 
include well recognised practices that are 
known to contribute to production of 
high quality milk. Several studies have 
indicated that the risk of new IMI can be 
reduced by ensuring that milking tech-
nicians wear disposable nitrile or latex 
gloves (Rodrigues et al. 2005; Dufour 
et al. 2011). Essential aspects of an effec-
tive pre-milking routine include effective 
teat disinfection, examination of foremilk, 
sufficient stimulation to allow for effec-
tive milk let-down, complete drying of the 
teats and timely attachment of the milking 
unit. Research has definitively established 
that the gold standard for premilking teat 
disinfection is the application of an effec-
tive disinfectant for a sufficient contact 
time, followed by drying the teat using a 
single cloth or paper towel for each cow 
(Galton et al. 1984; Galton, Petersson 
and Merrill 1986). To ensure that clinical 
mastitis is detected and abnormal milk 
does not enter the human food chain, two 
or three streams of foremilk should be 
removed and examined before attaching 
milking units. Drying of teats has been 
demonstrated to reduce bacterial counts 
of teat ends (Galton et al. 1986) reduce 
the number of colonies of spore form-
ing bacteria in bulk milk (Rasmussen, 
Galton and Petersson 1991), and to effec-
tively reduce the risk of contaminating 
milk with iodine residues from pre-dips 
(Borucki-Castro et al. 2010). The use of 
automatic take-off units is encouraged 
as they increase consistency of milking 
and allow milking technicians to spend 
more time on pre-milking preparation. 
Effective post-milking teat disinfection 
is fundamental to control of contagious 
pathogens (Keefe 2012). The principle is 
based on killing pathogens deposited on 
the teat skin during the milking process 
before they colonise the teat orifice and 
invade the gland and effective applica-
tion of post-milking teat dips can result 
in >50% reduction in new IMI (Harmon 
1996). Post-milking teat dipping is a high-
ly adopted practice, but it is not always 
properly implemented. Milking techni-
cians should be trained to use an appli-
cation method that ensures that at least 
75% of the teat skin is covered with an 
approved, commercially formulated teat 
disinfectant. Efficacy of the post-milking 
teat dip should have been demonstrated 
through properly performed scientific tri-
als. A list of peer-reviewed publications 
about efficacy trials of teat dips is updated 
annually by the NMC (Anon. 2009).
 3. Farmers must identify and manage 
chronically infected cows. Cows that main-
tain more than 2 months of individual SCC 
>200,000 cells/mL and cows that experi-
ence repeated (>2 episodes) of clinical 
mastitis can be considered to be chroni-
cally infected. There are 6 options that 
can be considered for managing chronic 
cows to reduce BTSCC. 1) Economic 
models have demonstrated that treatment 
of subclinical infections during lactation is 
almost never cost effective (Swinkels et al. 
2005; Steeneveld, Swinkels and Hogeveen 
2007). Due to the value of milk and uncer-
tainty of treatment responses, treatment 
of cows with subclinical mastitis is rarely 
cost effectiveness and is generally only 
recommended when the IMI is caused 
by Streptococcus agalactiae (Keefe 2012). 
2) Physical segregation of chronically 
infected cows has been shown to be an 
effective method of reducing the new 
infection rate (Wilson, Gonzalez and 
Sears 1995; Zecconi, Piccinini and Fox 
2003), but is labour intensive and depen-
dent on use of consistent use of diagnos-
tic methods that can accurately detect 
infected cows. Many farmers arrange the 
milking order so that lower risk ani-
mals (first lactation cows or cows with 
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lower SCC) are milked first to reduce the 
risk of transmission of mastitis pathogens 
during the milking process. The use of 
automated disinfectants to back-flush the 
teat cups between cows has been demon-
strated to reduce the risk of developing 
new IMI caused by Staphylococcus aureus 
(Hogan et al. 1984), but the cost effective-
ness of these systems is dependent on the 
prevalence of infection within the herd. 3) 
Early dry off of the affected cow. While 
the use of intramammary dry cow therapy 
(DCT) remains an effective practice to 
prevent new IMI during the dry period, 
cure rates for chronic mastitis caused by 
Staphylococcus aureus remain relatively 
low even when multiple treatments or 
systemic therapies are added (Cummins 
and McCaskey 1987; Erskine et al. 1994; 
Nickerson et al. 1999). In general, most 
studies do not indicate that use of DCT 
and/or additional therapies at dry off 
result in cure of most chronically affected 
cows. Thus, when this strategy is used it 
should be accompanied by an effected 
surveillance programme that will limit the 
risk of transmission if the cow remains 
infected in the next lactation. 4) Dry off of 
the affected quarter. When a single mam-
mary gland quarter of a cow is chroni-
cally infected, farmers have the option 
of permanently drying off that quarter. 
Therapeutic cessation of lactation should 
be performed under veterinary supervi-
sion and is often accomplished by infusion 
of an irritating substance such as iodine 
or chlorhexidine into the mammary gland 
(Middleton and Fox 2001). This strategy 
reduces the shedding of SCC into milk 
and decreases the potential for transmis-
sion among cows. However, this inter-
vention is not therapeutic and must be 
accompanied by an intensive strategy to 
prevent new infections. 5) Segregation 
and discard of milk from affected quar-
ters. In some instances, when there is a 
need to rapidly reduce the BTSCC with-
out excessive culling, individual “quar-
ter-milking” containers can be used to 
reduce cross contamination of milking 
clusters and to reduce the BTSCC. These 
small containers are inserted into the 
milking cluster to divert from chroni-
cally affected quarters away from the 
bulk tank. If these devices are used, they 
should be considered as potential fomites 
for transmission to other cows, and they 
should be carefully washed and dried 
after each use. 6) Culling of the cow. The 
prevalence of chronically infected cows 
is a strong predictor of risk of new IMI 
for pathogens that can be transmitted 
in a contagious manner. When possible, 
culling is a preferred strategy to man-
age many chronically affected cows. One 
study demonstrated that the odds of a cow 
becoming infected with S. aureus doubled 
with each 5% increase in the herd preva-
lence of existing infection (Dufour et al. 
2012). Chronically infected cows must 
be identified through routine testing of 
individual cows SCC and microbiological 
analysis should be performed to iden-
tify the causative pathogens. Cows that 
develop chronic infections with pathogens 
that are refractory to treatment should be 
culled to reduce the risk of transmission 
to healthy animals.
Summary
The production of high quality milk 
is vital for dairy producers to remain 
competitive in the global dairy industry. 
Reducing bulk tank SCC is based on 
adoption of well-known best manage-
ment practices that minimise develop-
ment of new IMI. Regular monitoring 
of individual cow SCC is an important 
tool that can be used by farmers and 
their advisors to develop and implement 
annual udder health plans. 
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